These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31919335)

  • 1. Identification of a variant hotspot in MYBPC3 and of a novel CSRP3 autosomal recessive alteration in a cohort of Polish patients with hypertrophic cardiomyopathy.
    Lipari M; Wypasek E; Karpiński M; Tomkiewicz-Pajak L; Laino L; Binni F; Giannarelli D; Rubiś P; Petkow-Dimitrow P; Undas A; Grammatico P; Bottillo I
    Pol Arch Intern Med; 2020 Feb; 130(2):89-99. PubMed ID: 31919335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First identification of homozygous truncating CSRP3 variants in two unrelated cases with hypertrophic cardiomyopathy.
    Janin A; Bessière F; Chauveau S; Chevalier P; Millat G
    Gene; 2018 Nov; 676():110-116. PubMed ID: 30012424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSRP3, p.Arg122*, is responsible for hypertrophic cardiomyopathy in a Chinese family.
    Huang H; Chen Y; Jin J; Du R; Tang K; Fan L; Xiang R
    J Gene Med; 2022 Jan; 24(1):e3390. PubMed ID: 34558151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide study on hypertrophic cardiomyopathy in Iceland: evidence of a MYBPC3 founder mutation.
    Adalsteinsdottir B; Teekakirikul P; Maron BJ; Burke MA; Gudbjartsson DF; Holm H; Stefansson K; DePalma SR; Mazaika E; McDonough B; Danielsen R; Seidman JG; Seidman CE; Gunnarsson GT
    Circulation; 2014 Sep; 130(14):1158-67. PubMed ID: 25078086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p.(Cys150Tyr) variant in CSRP3 is associated with late-onset hypertrophic cardiomyopathy in heterozygous individuals.
    Salazar-Mendiguchía J; Barriales-Villa R; Lopes LR; Ochoa JP; Rodríguez-Vilela A; Palomino-Doza J; Larrañaga-Moreira JM; Cicerchia M; Cárdenas-Reyes I; García-Giustiniani D; Brögger N; Fernández G; García S; Santiago L; Vélez P; Ortiz-Genga M; Elliott PM; Monserrat L
    Eur J Med Genet; 2020 Dec; 63(12):104079. PubMed ID: 33035702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of hypertrophic cardiomyopathy in eastern Finland: few founder mutations with benign or intermediary phenotypes.
    Jääskeläinen P; Miettinen R; Kärkkäinen P; Toivonen L; Laakso M; Kuusisto J
    Ann Med; 2004; 36(1):23-32. PubMed ID: 15000344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal recessive transmission of MYBPC3 mutation results in malignant phenotype of hypertrophic cardiomyopathy.
    Wang Y; Wang Z; Yang Q; Zou Y; Zhang H; Yan C; Feng X; Chen Y; Zhang Y; Wang J; Zhou X; Ahmad F; Hui R; Song L
    PLoS One; 2013; 8(6):e67087. PubMed ID: 23840593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of MYBPC3 Gene Mutations in Patients with Hypertrophic Cardiomyopathy, Reporting Two Novel Mutations from North-West of Iran.
    Emrahi L; Tabrizi MT; Gharehsouran J; Ardebili SM; Estiar MA
    Clin Lab; 2016; 62(5):757-64. PubMed ID: 27348999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy.
    Geier C; Gehmlich K; Ehler E; Hassfeld S; Perrot A; Hayess K; Cardim N; Wenzel K; Erdmann B; Krackhardt F; Posch MG; Osterziel KJ; Bublak A; Nägele H; Scheffold T; Dietz R; Chien KR; Spuler S; Fürst DO; Nürnberg P; Ozcelik C
    Hum Mol Genet; 2008 Sep; 17(18):2753-65. PubMed ID: 18505755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel FHL1 mutation variant identified in a patient with nonobstructive hypertrophic cardiomyopathy and myopathy - a case report.
    Giucă A; Mitu C; Popescu BO; Bastian AE; Capşa R; Mursă A; Rădoi V; Popescu BA; Jurcuţ R
    BMC Med Genet; 2020 Sep; 21(1):188. PubMed ID: 32993534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening Mutations of MYBPC3 in 114 Unrelated Patients with Hypertrophic Cardiomyopathy by Targeted Capture and Next-generation Sequencing.
    Liu X; Jiang T; Piao C; Li X; Guo J; Zheng S; Zhang X; Cai T; Du J
    Sci Rep; 2015 Jun; 5():11411. PubMed ID: 26090888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
    Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
    Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial and Functional Distribution of
    Helms AS; Thompson AD; Glazier AA; Hafeez N; Kabani S; Rodriguez J; Yob JM; Woolcock H; Mazzarotto F; Lakdawala NK; Wittekind SG; Pereira AC; Jacoby DL; Colan SD; Ashley EA; Saberi S; Ware JS; Ingles J; Semsarian C; Michels M; Olivotto I; Ho CY; Day SM
    Circ Genom Precis Med; 2020 Oct; 13(5):396-405. PubMed ID: 32841044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Founder mutation in myosin-binding protein C with an early onset and a high penetrance in males.
    Méndez I; Fernández AI; Espinosa MÁ; Cuenca S; Lorca R; Rodríguez JF; Tamargo M; García-Montero M; Gómez C; Vilches S; Vázquez N; Álvarez R; Medrano C; Yotti R; Fernández-Avilés F; Bermejo J
    Open Heart; 2021 Sep; 8(2):. PubMed ID: 34588271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reevaluation of the South Asian
    Harper AR; Bowman M; Hayesmoore JBG; Sage H; Salatino S; Blair E; Campbell C; Currie B; Goel A; McGuire K; Ormondroyd E; Sergeant K; Waring A; Woodley J; Kramer CM; Neubauer S; Farrall M; Watkins H; Thomson KL;
    Circ Genom Precis Med; 2020 Jun; 13(3):e002783. PubMed ID: 32163302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy.
    Friedrich FW; Wilding BR; Reischmann S; Crocini C; Lang P; Charron P; Müller OJ; McGrath MJ; Vollert I; Hansen A; Linke WA; Hengstenberg C; Bonne G; Morner S; Wichter T; Madeira H; Arbustini E; Eschenhagen T; Mitchell CA; Isnard R; Carrier L
    Hum Mol Genet; 2012 Jul; 21(14):3237-54. PubMed ID: 22523091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
    Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole MYBPC3 NGS sequencing as a molecular strategy to improve the efficiency of molecular diagnosis of patients with hypertrophic cardiomyopathy.
    Janin A; Chanavat V; Rollat-Farnier PA; Bardel C; Nguyen K; Chevalier P; Eicher JC; Faivre L; Piard J; Albert E; Nony S; Millat G
    Hum Mutat; 2020 Feb; 41(2):465-475. PubMed ID: 31730716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene.
    Lekanne Deprez RH; Muurling-Vlietman JJ; Hruda J; Baars MJ; Wijnaendts LC; Stolte-Dijkstra I; Alders M; van Hagen JM
    J Med Genet; 2006 Oct; 43(10):829-32. PubMed ID: 16679492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy-linked variants of cardiac myosin-binding protein C3 display altered molecular properties and actin interaction.
    Da'as SI; Fakhro K; Thanassoulas A; Krishnamoorthy N; Saleh A; Calver BL; Safieh-Garabedian B; Toft E; Nounesis G; Lai FA; Nomikos M
    Biochem J; 2018 Dec; 475(24):3933-3948. PubMed ID: 30446606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.